Oxford Capital Partners
Home Investor Login
  • Home
  • About Us
  • For Investors
  • For Companies
  • Team
  • Portfolio
  • Awards
  • News
  • Investors Forum
  • Careers
  • Links
  • Contact

Home

Oxford Capital Partners is a venture capital firm working on behalf of institutional and private investors. Its focus is on emerging science and technology and its expertise lies in accelerating businesses with potential for high growth in global markets. Oxford Capital Partners looks for the best opportunities, backing exceptional management teams and investing across all stages of development, from start-up to IPO. Leveraging its extensive world-wide networks, Oxford Capital Partners assists portfolio companies in accessing international markets in Europe, the US, Middle East and Asia. Oxford Capital Partners is the manager of several Funds and oversees a portfolio of companies in a range of technology sectors, including clean technologies, communication technologies, healthcare and related life and physical sciences.

Oxford Capital Partners was named Venture Capital House of the Year 2005
at the Unquote Awards.

Latest News

Oxford Capital Partners Latest
6 May 2008 Oxford Capital Partners Features in Real Deals Magazine
30 April 2008 Oxford Capital Partners announces investment in Sirigen Limited
22 February 2008 Oxford Capital Partners features on FT.com Podcast
22 February 2008 Oxford Capital Partners announces investment in Arieso Limited
18 February 2008 Oxford Capital Partners announces investment in Exosect Limited
22 January 2008 Oxford Capital Partners announces investment in Microbial Solutions Limited
14 November 2007 Oxford Capital Partners announces investment in Teepix plc
17 October 2007 Oxford Capital Partners announces investment in Green Biologics Limited
4 September 2007 Oxford Capital Partners announces investment in Oxitec Limited
10 August 2007 Oxford Capital Partners announces investment in Glide Pharmaceutical Technologies Limited
25 June 2007 Oxford Capital Partners announces investment in Inetec Limited
11 May 2007 Oxford Capital Partners announces investment in Veryan Medical

Portfolio Companies Latest
10 May 2008 Exosect Exosect Appoints David Sherwood As Formulations Manager
6 May 2008 Green Biologics Green Biologics Announces New Management Team Appointments
4 April 2008 Oxonica Oxonica receives US$2.15m of purchase orders for Security Business
28 March 2008 Orthomimetics OrthoMimetics Wins Rising Star Award
3 March 2008 Oxonica Oxonica launches OptisolTM Sun Defence
18 February 2008 Oxford Genome Sciences Oxford Genome Sciences Appoints Professor Elke Jaeger to its Scientific Advisory Board
18 February 2008 Oxonica Oxonica Announces Stagecoach Trial of its Envirox Fuel Catalyst Successful
5 February 2008 Helveta Helveta and SGS announce agreements for a nationwide forest and timber chain-of-custody monitoring system in the Republic of Liberia
30 January 2008 Helveta Helveta BBC News Report- GPS Helps Pygmies Defend Home
23 January 2008 Orthomimetics OrthoMimetics Awarded £747k Grant to Develop Second Product
17 December 2007 Oxford Genome Sciences Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in cancer
13 December 2007 Oxonica Successful completion of technical milestones leads to follow-on orders
30 November 2007 Oxitec Oxitec wins global award for dengue control
29 November2007 Oxitec Oxitec selected as a Technolgy Pioneer by the World Economic Forum
21 November 2007 Oxford Genome Sciences Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
30 October 2007 Celoxica Celoxica bolster boardroom team to capitalise on lucrative Financial Services market
26 October 2007 Hardide Hardide secures global gas supply agreement with BOC
11 October 2007 Oxford Genome Sciences Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
8 October 2007 Helveta Helveta BBC News and Radio Coverage – Logging With Care in The Congo
27 September 2007 Oxonica Oxonica Signs Follow-on Research and Development Agreement with BD
20 September 2007 Hardide Hardide approved by U.S. Food and Drug Administration for Food Processing
20 September 2007 Hardide UK Smallcap Opening – Hardide Higher on FDA OK for Component Coating
18 September 2007 Oxford Genome Sciences Oxford Genome Sciences Announces New Therapeutic Antibody Deal with Medarex
17 September 2007 Celoxica Celoxica Acceleration Cards Qualified in HP Servers
12 September 2007 Oxitec Oxitec Appoints Regulatory Manager
11 September 2007 Ad.IQ Global TXT4 Rebrands as Ad.IQ Global
11 September 2007 Oxonica New Supply and Distribution Agreement for Oxonica
3 September 2007 Helveta Helveta issues new release of innovative CI World technology
3 September 2007 Hardide Hardide secures Weatherford as new customer in UK and US
28 August 2007 Celoxica Celoxica sees increased demand for Accelerated Computing in Financial Services
21 August 2007 Hardide Hardide to Fast Track Aerospace Market Development plans
12 August 2007 Rostima Rostima in Telegraph – Highly intelligent workforce scheduling systems to help eradicate lengthy queues
About Us »

Please click here for important legal and regulatory information
© 1999-2008 Oxford Capital Partners Limited, 201 Cumnor Hill, Oxford, OX2 9PJ, UK.
Telephone: +44 (0) 1865 860 760, Fax: +44 (0) 1865 860 761, e-mail: info@oxcp.com.